Latest abdominal surgery Stories

- Patients experienced significantly greater reduction in pain as measured by SPID-48 vs. placebo (p=0.001) - REDWOOD CITY, Calif., March 4, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced top-line data results demonstrating that the first of two pivotal placebo-controlled Phase 3...

CENTER VALLEY, Pa. and SOUTHBOROUGH, Mass., Oct. 1, 2012 /PRNewswire/ -- Olympus announces the availability of a revolutionary surgical system allowing surgeons to remove the gallbladder through the belly button using a single incision of only 12-15mm in size - a solution only Olympus is offering at this time. This one-of-a-kind system, developed over a five year period, will better enable Laparoendoscopic Single Site Surgery (LESS) and encourage a wider spread adoption of using a...

ASHBURN, Va., Feb. 1, 2012 /PRNewswire/ -- Innocoll Inc. announced it has entered into a License and Distribution Agreement with Flynn Pharma Ltd. in the United Kingdom and with Inresa Arzneimittel GmbH in Germany for CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery. Dr. Michael Myers, President and CEO stated, "We are pleased to announce these partnerships for two of the key markets in the EU and we look...

With the number of women having cesarean sections on the rise, the risk of post-operative abdominal scar tissue, or adhesions, among mothers may also be increasing. Adhesion Related Disorder activist Karen Steward today joined the call for obstetricians to consider the risk of adhesion-related complications when recommending cesarean versus vaginal delivery. (PRWEB) January 27, 2012 Author and activist Karen Steward today responded to an article published in the December 2011 issue of the...

ASHBURN, Va., Nov. 15, 2011 /PRNewswire/ -- Innocoll Inc. announced it has entered into a License and Distribution Agreement with Merus Labs Inc. in Canada for CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery. Dr. Michael Myers, President and CEO stated, "We are pleased to announce the expansion of our partnership with Merus to include CollaGUARD and we look forward to the successful launch of the product in Canada."...

ASHBURN, Va. ,Oct. 19, 2011 /PRNewswire/ -- Innocoll, Inc. announced it has entered into a License and Distribution Agreement with Pioneer Pharma in China for CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery. Dr. Michael Myers, President and CEO stated "This is an exciting development for Innocoll. China is becoming an increasingly important and dynamic market for medical products and we are very pleased to have...

ASHBURN, Va., Oct. 11, 2011 /PRNewswire/ -- Innocoll, Inc. announces the approval of CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery. The product will be launched this year through a network of distribution partnerships. The company also plans to seek approval in a number of additional territories, including Australia, Canada, the MENA region, South East Asia, and to initiate the studies required for registration in...

GENEVA, August 11, 2010 /PRNewswire/ -- PregLem, the Swiss specialty biopharmaceutical company focused on women's reproductive medicine, announces a world-wide, exclusive in licensing agreement for Bentamapimod, a novel, orally active, Jun Kinase Inhibitor (JNK-I AS602801) from Merck Serono for an undisclosed amount. PregLem will develop the compound for the prevention of post-surgical abdominal adhesions and endometriosis in patients with tubal ligation or comparable effective...

The risk of complications and early death after commonly performed abdominal surgical procedures appears to be higher among older adults, according to a report in the December issue of Archives of Surgery, one of the JAMA/Archives journals.It is estimated that one in six Americans will be age 65 or older by 2020 and that 15 percent of this population will be older than age 85, according to background information in the article. "Approximately 2 million older Americans undergo abdominal...

Can abdominal organs be removed with only regional pain relief?A recent review in Faculty of 1000 Medicine Reports, a publication in which clinicians highlight advances in medical practice, suggests regional pain relief could be used during abdominal surgery. In this review, Michael Schaefer recommends a new approach that can be performed without the need for general anaesthetics.Currently, abdominal surgery is often carried out through laparoscopy, in which surgical tools are manoeuvred...